Concin N, Braicu I, Combe P, Berger R, et al. GANNET53 Part II: A European Phase I/II Trial of the HSP90 inhibitor Ganetespib in high-grade Platinum-Resistant Ovarian Cancer - A Study of the GANNET53 consortium. Clin Cancer Res 2025 May 28. doi: 10.1158/1078-0432.CCR-24-3705.
PMID: 40435111